5/7: Complications of Mucositis can lead to appetite loss, increased infection risk, septicemia, and nutrient deficiencies, especially in cancer patients, posing additional challenges during recovery.

Hindi television and Bollywood actor Hina Khan took to Instagram recently to talk about her struggle with mucositis. Mucositis is a common side effect experienced by cancer patients while ...

The tissue destruction and functional alterations in the oral cavity lead to the development of oral mucositis. The purpose of this review is to describe the mechanisms, risk factors, prevalence ...

Oropharyngeal mucositis is an acute and distressing toxic effect of chemotherapy and head and neck irradiation. This oral sequela significantly impairs the daily functioning and quality of life of ...

Mucositis is a common and often painful side effect of cancer treatments like chemotherapy and radiation. It refers to the inflammation and ulceration of the mucous membranes lining the digestive ...

The patient's diarrhea remained only moderate, but her mucositis was severe and persistent. The mucositis impeded oral ingestion despite the care applied to the mouth and the administration of ...

The report provides a comprehensive analysis of the global chemotherapy-induced oral mucositis market, highlighting key trends, drivers, and challenges shaping the industry. The estimated to secure a ...

On Thursday, Soligenix Inc. (NASDAQ:SNGX) opened patient enrollment for its DUS-AUBD-01 Phase 2 study evaluating SGX945 ...

Doctors say they are seeing an unusual spike in walking pneumonia cases in parts of Canada, particularly in children, but say ...

cleared cryotherapy device designed to reduce the incidence and severity of chemotherapy induced oral mucositis. In connection with the investment, the Company announced the execution of an exclusive ...

Sanara MedTech Inc (SMTI) achieves its 12th consecutive record revenue quarter, while navigating increased expenses and ...

Continued enrollment and dose escalation in Phase 1 study of VIP943, a potentially best-in-class anti-CD123 antibody-drug ...